Onward Medical Past Earnings Performance

Past criteria checks 0/6

Onward Medical's earnings have been declining at an average annual rate of -20.4%, while the Medical Equipment industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 19% per year.

Key information

-20.4%

Earnings growth rate

30.6%

EPS growth rate

Medical Equipment Industry Growth12.3%
Revenue growth rate19.0%
Return on equity-105.6%
Net Margin-7,240.0%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Onward Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTBR:ONWD Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 231-3600
30 Sep 231-3682
30 Jun 232-36175
31 Mar 232-34155
31 Dec 222-33146
30 Sep 222-35156
30 Jun 222-38156
31 Mar 222-36145
31 Dec 211-34135
30 Sep 211-29104
30 Jun 211-2473
31 Mar 211-2263
31 Dec 201-2053
31 Dec 191-1341
31 Dec 180-1021

Quality Earnings: ONWD is currently unprofitable.

Growing Profit Margin: ONWD is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ONWD is unprofitable, and losses have increased over the past 5 years at a rate of 20.4% per year.

Accelerating Growth: Unable to compare ONWD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ONWD is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (5.2%).


Return on Equity

High ROE: ONWD has a negative Return on Equity (-105.63%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.